Literature DB >> 18817762

Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody.

Ling Zhang1, Chunyan Zhang, Yuangang Zhu, Qing Cai, Piu Chan, Kenji Uéda, Shun Yu, Hui Yang.   

Abstract

Alpha-synuclein (alpha-Syn) is a brain-enriched protein of 140 amino acids. Despite of strong evidence showing the implication of the protein in the pathogenesis of several neurodegenerative diseases, its physiological function remains poorly understood. To study the physiological function of alpha-Syn, a depiction of its precise subcellular localization is necessary. Although alpha-Syn expression in the brain has been extensively investigated using several different antibodies, its precise subcellular localization in neurons remains elusive. In this study, immunogold electron microscopy with a newly produced 3D5 monoclonal antibody recognizing the C-terminal 115-121 amino acids of alpha-Syn was used to examine its subcellular localization in rat brain neurons. In addition, the relative amount of the protein in different subcellular pools of the neurons in several brain regions was evaluated and compared. The results showed that alpha-Syn-positive gold particles were unevenly distributed in axons, presynaptic terminals, cytoplasm and nucleus in the neuron, with the density of gold particles being greater in presynaptic terminals and nucleus than in other subcellular pools. In the cytoplasmic region, relatively dense gold particles were seen in some mitochondria. In the same subcellular pools, the density of gold particles was varied among the neurons from different brain regions. Although the cortical neurons showed much higher density of gold particles in the presynaptic terminals and nuclei than in striatal, hippocampal and substantia nigral neurons, the density of gold particles in their mitochondria was much lower compared with the mitochondria of striatal, hippocampal and substantia nigral neurons. The relative high level of mitochondrial alpha-Syn in hippocampus, striatum and substantia nigral neurons may have special pathophysiological significance, which deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817762     DOI: 10.1016/j.brainres.2008.08.067

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  46 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  Impact of membrane curvature on amyloid aggregation.

Authors:  Mayu S Terakawa; Yuxi Lin; Misaki Kinoshita; Shingo Kanemura; Dai Itoh; Toshihiko Sugiki; Masaki Okumura; Ayyalusamy Ramamoorthy; Young-Ho Lee
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-28       Impact factor: 3.747

3.  Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.

Authors:  Velmarini Vasquez; Joy Mitra; Pavana M Hegde; Arvind Pandey; Shiladitya Sengupta; Sankar Mitra; K S Rao; Muralidhar L Hegde
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Familial Parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of α-synuclein.

Authors:  Shruti Sahay; Dhiman Ghosh; Saumya Dwivedi; Arunagiri Anoop; Ganesh Maruti Mohite; Mamata Kombrabail; Guruswamy Krishnamoorthy; Samir K Maji
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 5.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 6.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

Review 7.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

8.  The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

Authors:  Virginie Loeb; Eugenia Yakunin; Ann Saada; Ronit Sharon
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

9.  Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation.

Authors:  Han Cheng; Lei Wang; Chih-chen Wang
Journal:  Cell Stress Chaperones       Date:  2009-12-04       Impact factor: 3.667

Review 10.  Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.